MeSH Browser

MeSH Supplementary: althiazide, canrenoate potassium, rescinnamine drug combination
Unique ID: C006445
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C006445
Entry Term(s): aldatense; althiazide - canrenoate potassium - rescinnamine
Registry Numbers: 76270-05-8
CAS Type 1 Name: Yohimban-16-carboxylic acid, 11,17-dimethoxy-18-((1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl)oxy)-, methyl ester, (3beta,16beta,17alpha,18beta,20alpha)-, mixt. with 6-chloro-3,4-dihydro-3-((2-propenylthio)methyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide and (17alpha)-17-hydroxy-3-oxopregna-4,6-diene-21-carboxylic acid monopotassium salt
Previous Indexing: *ANDROSTENOLS (74-75); *RESCINNAMINE (74-94)
Heading Mapped to: *Canrenoic Acid; Drug Combinations; Reserpine / analogs & derivatives; *Sulfonamides
Frequency: 2
Note: combination drug of canrenoate potassium, altizide, rescinnamine; structure
Source: Minerva Cardioangiolog 2(9):585;1973
Date of Entry: 1974/01/01
Revision Date: 2012/11/05

althiazide, canrenoate potassium, rescinnamine drug combination MeSH Supplementary Concept Data 2025